Respiratory Medicine
Volume 100, Issue 9 , Pages 1642-1646 , September 2006

Variation in lung cancer survival rates between countries: Do differences in data reporting contribute?

  • Claire A. Butler

      Affiliations

    • Department of Respiratory Medicine, United Hospitals NHS Trust, Bush Road, Antrim BT41 2QB, Northern Ireland, UK
    • Queens University Belfast, UK
  • ,
  • Karen M. Darragh

      Affiliations

    • Department of Respiratory Medicine, United Hospitals NHS Trust, Bush Road, Antrim BT41 2QB, Northern Ireland, UK
    • Queens University Belfast, UK
  • ,
  • Graeme P. Currie

      Affiliations

    • Chest Clinic C, Aberdeen Royal Infirmary, Aberdeen AB25 2DZ, Scotland, UK
  • ,
  • Wendy J.A. Anderson

      Affiliations

    • Department of Respiratory Medicine, United Hospitals NHS Trust, Bush Road, Antrim BT41 2QB, Northern Ireland, UK
    • Queens University Belfast, UK
    • Corresponding Author InformationCorresponding author. Department of Respiratory Medicine, United Hospitals NHS Trust, Bush Road, Antrim BT41 2QB, Northern Ireland, UK

Received 1 October 2005 ,Accepted 11 December 2005.

References 

  1. Coleman MP, Gatta G, Verdecchia A, Esteve J, Sant M, Storm H, et al. EUROCARE-3 summary: cancer survival in Europe at the end of the 20th century. Ann Oncol. 2003;14(Suppl 5):v128–v149
  2. Cancerstats monograph: cancer research UK, 2004. p. 45–54.
  3. Gregor A, Thomson CS, Brewster DH, Stroner PL, Davidson J, Fergusson RJ, et al. Management and survival of patients with lung cancer in Scotland diagnosed in 1995: results of a national population based study. Thorax. 2001;56:212–217
  4. SEER. www.seer.gov., 2005.
  5. Gregor A, Macbeth F. Non-small cell lung cancer: are we out of step?. Clin Oncol (R Coll Radiol). 1995;7:2–3
  6. Sikora K. Cancer survival in Britain. Brit Med J. 1999;319:461–462
  7. Watson R. Europe is a ‘second class continent’ for cancer research. Brit Med J. 2005;330:746
  8. Department of Health. http://www.doh.gov.uk/cancer. The NHS Cancer Plan. London, 2000.
  9. Department of Health. Improving outcomes in lung cancer: the manual. London: Department of Health; 1998;
  10. Berrino F. The EUROCARE study: strengths, limitations and perspectives of population-based, comparative survival studies. Ann Oncol. 2003;14(Suppl 5):v9–v13
  11. National cancer plan report 2: epimemiology. Copenhagen, 2000.
  12. Scottish Health Statistics. www.isdscotland.org/.
  13. Fitzpatrick D, Gavin A, Middleton R, Catney D. Cancer in Northern Ireland 1993–2001. A Comprehensive report. Belfast: Northern Ireland Cancer Registry. Queens University Belfast; 2004;
  14. Capocacia R, Gatta G, Roazzi P, carrani E, Santaquilani M, Angelis RD, et al. The EUROCARE-3 database: methodology of data collection, stanadardisation, quality control and statistical analysis. Ann Oncol. 2003;14(Suppl 5):v14–v27
  15. EUROCARE-2. Special Issue. Eur J Cancer. 1998;34(14):
  16. Billing JS, Wells FC. Delays in the diagnosis and surgical treatment of lung cancer. Thorax. 1996;51:903–906
  17. Seel M, Foroudi F. Waiting for radiation therapy: does it matter?. Australas Radiol. 2002;46:275
  18. Saving lives: our healthier nation. London: Department of Health; 1999;
  19. O’Rourke N, Edwards R. Lung cancer treatment waiting times and tumour growth. Clin Oncol (R Coll Radiol). 2000;12:141–144
  20. Berrino F, Saut M, Verdecchia A, et al. Survival of cancer patients in Europe. The Eurocare study. Geneva: IARC Scientific Publications; 1995;
  21. Humphrey EW, Smart CR, Winchester DP, et al. National survey of the pattern of care for carcinoma of the lung. J Thoracic Cardiovasc Surg. 1990;100:837–843
  22. Saunders MI, Dische S, Barrett A, Harvey A, Gibson D, Parmar M. A randomised multicentre trial of CHART vs. conventional radiotherapy in non-small cell lung cancer. Lancet. 1997;350:161–165
  23. Gatta G. Toward a comparison of survival in American and European cancer patients. Cancer. 2000;89:893–900
  24. seer.cancer.gov. SEER cancer statistics review, 1975–2001. 2005. p. 26–8.
  25. Hakulinen T. Cancer survival corrected for heterogeneity in patient withdrawal. Biometrics. 1982;38:933–942

PII: S0954-6111(05)00539-1

doi: 10.1016/j.rmed.2005.12.006

Respiratory Medicine
Volume 100, Issue 9 , Pages 1642-1646 , September 2006